Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2007-04-03
2007-04-03
Chen, Stacy B. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
Reexamination Certificate
active
10601020
ABSTRACT:
Novel hepatitis C virus (HCV) polypeptides are provided which are not encoded by the standard HCV open reading frame. These alternate reading frame polypeptides are useful, inter alia, in vaccine compositions, in diagnosing HCV infection, and as therapeutic targets.
REFERENCES:
patent: 5350671 (1994-09-01), Houghton et al.
patent: 5443965 (1995-08-01), Reyes et al.
patent: 5728520 (1998-03-01), Weiner et al.
patent: 5840839 (1998-11-01), Wang et al.
patent: 5922532 (1999-07-01), Deleys et al.
patent: 6027729 (2000-02-01), Houghton et al.
patent: 6054264 (2000-04-01), Chien et al.
patent: 6074846 (2000-06-01), Ralston et al.
patent: 6150087 (2000-11-01), Chien
patent: 6171782 (2001-01-01), Houghton et al.
patent: 7052830 (2006-05-01), Branch et al.
patent: WO 94/25601 (1994-11-01), None
patent: WO 94/25601 (1994-11-01), None
patent: WO 96/05315 (1996-02-01), None
patent: WO 96/05315 (1996-02-01), None
patent: WO 96/40227 (1996-12-01), None
Walewski et al., RNA, 2002, vol. 8, p. 557-571.
Walewski et al., RNA, 2001, vol. 7, p. 710-721.
Boulani, S. et al “Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein fom Genotype 1b.”J Biol Chem.Nov. 14, 2003: 278(46).45785-92.
Branch, A D , et al “The hepautus C virus alternate reading frame (ARF) and its family of novel products the alternate reading frame protein/F-protein, the double-frameshift protein, and others.”Semin Liver DisFeb. 25, 2005(1) 105-17.
Choi, J et al “Triple decoding of hepatitis C virus RNA by programmed translational frameshifting.”Mol Call Biol. Mar. 23, 2003(5). 1489-97.
Komurian-Pradel, F., et al “Antigenic relevance of F protein in chronic hepatitis C virus infection, ”Hepatology. Oct. 2004 40(4) 900-9.
Ogata, S , et al “Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma.”J Clin Microbiol. Oct. 2002 40(10):3625-30.
Rodriguez-Lopes, M. “Immunogenecity of variable regions of hepatitis C proteins ”Journ. Of Gen. Virol. 1999, BO 727-73.
Roussel, J., et al. “Characterization of expression of the Hepatitis C virus F protein”J virol2003, 84 1751-1759.
Tan. S-L., et al. “Hepatitis C therapeutics current status and emerging strategies.”NatureNov. 1, 2002 867-881.
Vassilaki, N et al. “Two alternative translation mechanisms are responsible for the expression of the HCV ARFT/F/Core +1 coding open reading frame”J Biol Chem.Oct. 2003 278 40503-40513.
Walewski, J.L., et al. “Reading between the lines evidence for a new Hepatitis C virus protein.”Hepatology.Sep. 2003 36(3) 757-60.
Walewski, J L , et al “Mutation Master profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions,”RNA. May 8, 2002(5). 557-71.
Walewski, J.L., et al. “Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame.”RNA. May 7, 2001(5).710-21.
Walewski, J L , et al. “HCV patients have antibodies against a novel protein encoded in a second reading frame.”Hepatology 28(4, Pt. 2):278A, Abstr. 462 (Oct. 1998).
Xu. Z., et al. “Hepatitis C virus F protein is a short-lived protein associated with the endoplasmic reticulum”J Virol. Jan. 2003; 77(2):1578-83.
Yeh, C-T , et al. “Amino acid substitutions in codons 9-11 of hepatitis C virus core protein lead to the synthesis of a short core protein product.”J Gastroenterol Hepatol. Feb. 2000; 15(2) 182-91.
Bullock, T.N.J. et al., “Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames,”J. Exp. Med., 184:1319-29 (1996).
Feucht, H.-H. et al. “Study on Reliability of Commercially Available Hepatitis C Virus Antibody Tests”Journal of Clinical Microbiology33(3):620-624 (Mar. 1995).
Ina, Y. et al. “Reduction of synonymous substitutions in the core protein gene of hepatitis C virus,”J. Mol. Evol., 38:50-56 (1994).
Lo, S.-Y. et al. “Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution”.Virology199(1):124-31(Feb. 15, 1994).
Lo, S.-Y. et al. “Differential subcellular localization of hepatitis C virus core gene products.”Virology213(2):455-61(Nov. 10, 1995).
Lo, S.-Y. et al. “Interaction between hepatitis C virus core protein and E1 envelope protein.”J. Virol.70(8):5177-82 (Aug. 1996).
Malarkannan, S. et al. “Presentation of out-of-frame peptide/MHC class l complexes by a novel translation initiation mechanism.”Immunity10(6):681-90 (Jun. 1999).
Ray, B.R et al. “Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype.”J. Virol.70(7):4438-43 (Jul. 1996).
Smith, D. B. et al. “Characteristics of nucleotide substitution in the hepatitis C virus genome: Constraints on sequence change in coding regions at both ends of the genome.”J. Mol. Evol., 45:238-246 (1997).
Valenzuela, P. et al. “The nucleotide sequence of the hepatitus B viral genome and the identification of the major viral genes. ” inAnimal Virus Genetics, Academic Press, pp. 57-70 (1980).
Varaklioti, A. et al. “Alternate translation occurs with the core coding region of the Hepatitis C viral genome.”Journal of Biological Chemistry277(20):17713-21 (2002).
Walewski, J.L. et al. “A western blot assay for detection of patient antibodies to an HCV alternate reading frame protein.”Abstract in Hepatology30(4):41A poster 163 (1999).
Walewski, J.L. et al. “HCV Patients Have Antibodies Against a Novel Protein Encoded in a Second Reading Frame.”Hepatology28(4, Pt. 2):278A, Abstr. 462 (Oct. 1998).
Wang, J. et al. “Proteolytic conversion of hepatitis B virus e antigen precursor to end product occurs in a postendoplasmic reticulum compartment.”J. Virol.65:5080-83 (Sep. 1991).
Xu, Z. et al. “Synthesis of a novel hepatitis C virus protein by ribosomal frameshift.”EMBO J.20(14):3840-48 (2001).
Branch Andrea D.
Stump Decherd D.
Walewski Jose L.
Boesen Agnieszka
Chen Stacy B.
Lahive & Cockfield LLP
LandOfFree
Hepatitis C virus peptides and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis C virus peptides and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus peptides and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3751423